Skip to main content
. Author manuscript; available in PMC: 2021 Mar 15.
Published in final edited form as: Mol Cell Endocrinol. 2020 Jan 11;504:110703. doi: 10.1016/j.mce.2020.110703

Figure 7:

Figure 7:

Effects of E2 versus Selective ER Agonist Treatment on 5’-AMP-Activated Protein Kinase (AMPK) Expression in Female or Male Hypothalamic Astrocytes. Data depict mean normalized AMPK O.D. measures ± S.E.M. for female [Panel 7A; p = 0.03] or male [Panel 7B; p = 0.61] astrocytes incubated with varying E2 doses. Panels 7C and 7D show effects of E2 versus selective ER agonists on female [p = 0.53] or male [p = 0.08] hypothalamic astrocyte AMPK content. *p < 0.05; **p < 0.01; ***p < 0.001.